Stay updated on KarXT Long-Term Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.

Latest updates to the KarXT Long-Term Safety in Schizophrenia Clinical Trial page
- CheckyesterdayChange DetectedThe page no longer displays the government funding notice and related topic links (Schizophrenia; MedlinePlus Genetics) that were present previously. These changes remove metadata/navigation items without affecting the core study details.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page shows minor formatting and layout changes with no changes to the study's key content.SummaryDifference0.4%

- Check29 days agoChange DetectedAdded a new MedlinePlus Genetics topic on schizophrenia, expanding core content related to a medical condition.SummaryDifference0.1%

- Check44 days agoChange DetectedMajor update: adds a government funding/operating status notice and updates version to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check51 days agoChange Detected- Added revision tag v3.1.0. - Removed the MedlinePlus Genetics topic on Schizophrenia and the previous revision tag v3.0.2.SummaryDifference0.2%

- Check65 days agoChange DetectedAdded a MedlinePlus Genetics topic on Schizophrenia and updated the page revision from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.3%

Stay in the know with updates to KarXT Long-Term Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.